Zymeworks BC Inc

Zymeworks BC Inc

ZYME

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.02B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Zymeworks BC IncZymeworks BC Inc-14--135%-0.4
$41.00

Target Price by Analysts

45.3% upsideZymeworks BC Target Price DetailsTarget Price
$-17.82

Current Fair Value

163.1% downside

Overvalued by 163.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.02 Billion
Enterprise Value$-144,900,215,028.00
Dividend Yield$- (-)
Earnings per Share$-1.08
Beta1.17
Outstanding Shares72,993,313

Return

Return on Equity-135.41%ROE
Return on Assets-27.41%
Return on Invested Capital-31.87%

Valuation & Multiples

P/E Ratio-13.97P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio0.03Price to Book Ratio
Enterprise Value to Revenue-57614.4
Enterprise Value to EBIT1.3
Enterprise Value to Net Income1
Total Debt to Enterprise-0.22
Debt to Equity0.4Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 6, 2026
EPS Estimate
$-0.57
Average shareholder expectation
Revenue Estimate
$4.54 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 5, 2026
EPS Estimate
$2.29
Average shareholder expectation
Revenue Estimate
$227.39 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000▼ 51.37%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %2.28%▼ 91.59%
Total Invested$44.10M▼ 97.54%
Investors Holding15▼ 193.00%

ESG Score

No data

About Zymeworks Inc

CEO: Ali Tehrani